Cochlear Ltd

COH

Company Profile

  • Business description

    Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.

  • Contact

    1 University Avenue
    Macquarie University
    SydneyNSW2109
    AUS

    T: +61 294286555

    E: [email protected]

    https://www.cochlear.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 June 2027

    Employees

    5,500

Cochlear Ltd News & Analysis

stocks

The ASX’s most shorted stocks before earnings

Where short sellers see risk ahead of earnings.
markets

The grass is always greener: Rethinking Australian vs global equities

How should investors think about Australia’s recent relative underperformance?
stocks

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,988.0019.10-0.21%
CAC 408,338.8139.05-0.47%
DAX 4024,830.9884.51-0.34%
Dow JONES (US)52,146.42406.55-0.77%
FTSE 10010,600.3728.130.27%
HKSE25,131.94569.702.32%
NASDAQ25,520.24361.70-1.40%
Nikkei 22564,141.122,694.42-4.03%
NZX 50 Index13,679.7514.93-0.11%
S&P 5007,457.6976.08-1.01%
S&P/ASX 2008,804.1018.20-0.21%
SSE Composite Index3,821.8657.701.53%

Market Movers